0.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze]
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
0.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze]
20 MG/ML · Injection · injection
A form of asparaginase Erwinia chrysanthemi (recombinant)-rywn →
0.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze] — Other antineoplastic agents. Strength, form, class, interactions & more.
![0.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=857e53aa-1098-4dad-b654-0276cdd43e03&name=image-01.jpg)
Active ingredient
Classification
Other antineoplastic agentsAsparagine-specific Enzyme
Real-world adverse events (FAERS)
Hyperammonaemia31Febrile Neutropenia25Nausea24Off Label Use24Hypersensitivity21Pancreatitis17Urticaria17Vomiting17
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication